Fungal infections in immunocompromised travelers

Clinical Infectious Diseases

Volumn 56, Issue 6, 2013, Pages 861-869

  Lortholary, Olivier ^a,b,c   Charlier, Caroline ^a   Lebeaux, David ^a   Lecuit, Marc ^a,b,d   Consigny, Paul Henri ^b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b INSTITUT PASTEUR   (France)

^c CNRS   (France)

^d INSERM   (France)

Author keywords

biologic immunomodulators; endemic areas; fungi; HIV; pregnancy; solid organ transplant; steroids; traveller

Indexed keywords

ANTINEOPLASTIC AGENT; DISEASE MODIFYING ANTIRHEUMATIC DRUG; METHOTREXATE; STEROID; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ARTICLE; AWARENESS; CLINICAL FEATURE; CYTOPENIA; DERMATOMYCOSIS; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; FEVER; GEOGRAPHIC DISTRIBUTION; GERIATRIC PATIENT; GRAFT RECIPIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPROMISED PATIENT; INFECTION PREVENTION; INFECTION RISK; LYMPHOMA; MYCOSIS; NEOPLASM; NEUTROPENIA; PNEUMONIA; PREGNANCY; PRIORITY JOURNAL; SKIN DEFECT; SUBCUTANEOUS NODULE; SYSTEMIC LUPUS ERYTHEMATOSUS; TRAVEL; TROPICS;

HIV INFECTIONS; HUMANS; IMMUNOCOMPROMISED HOST; MYCOSES; TRANSPLANTATION; TRAVEL;

EID: 84874773029     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cis935     Document Type: Article

References (117)

1. World Tourism Organization (UNWTO). Tourism highlights. 2012 edition. Available at: http://mkt.unwto.org/en/content/tourismhighlights. Accessed 25 November 2012.
2. Boggild AK, Sano M, Humar A, Salit I, Gilman M, Kain KC. Travel patterns and risk behavior in solid organ transplant recipients. J Travel Med 2004; 11:37-43.
3. Sherrard AW, McCarthy AE. Travel patterns and health risks for patients infected with HIV. Travel Med Infect Dis 2009; 7:291-5.
4. Baaten GG, Geskus RB, Kint JA, Roukens AH, Sonder GJ, van den Hoek A. Symptoms of infectious diseases in immunocompromised travelers: a prospective study with matched controls. J Travel Med 2011; 18:318-26.
5. Panackal AA, Hajjeh RA, Cetron MS, Warnock DW. Fungal infections among returning travelers. Clin Infect Dis 2002; 35:1088-95.
6. Wheat J. Endemic mycoses in AIDS: a clinical review. Clin Microbiol Rev 1995; 8:146-59.
7. Ampel NM. Coccidioidomycosis in persons infected with HIV type. Clin Infect Dis 2005; 41:1174-8.
8. Grimbacher B, Holland SM, Gallin JI, et al. Hyper-IgE syndrome with recurrent infections - an autosomal dominant multisystem disorder. N Engl J Med 1999; 340:692-702.
9. Smith DK, Neal JJ, Holmberg SD. Unexplained opportunistic infections and CD4+ T-lymphocytopenia without HIV infection: an investigation of cases in the United States. The Centers for Disease Control Idiopathic CD4+ T-lymphocytopenia Task Force. N Engl J Med 1993; 328:373-9.
10. Winkelstein JA, Marino MC, Ochs H, et al. The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients. Medicine 2003; 82:373-84.
11. Zerbe CS, Holland SM. Disseminated histoplasmosis in persons with interferon-gamma receptor 1 deficiency. Clin Infect Dis 2005; 41: e38-41.
12. Price CL, Hassi HO, English NR, Blakemore AI, Stagg AJ, Knight SC. Methylglyoxal modulates immune responses: relevance to diabetes. J Cell Mol Med 2010; 14:1806-15.
13. Delamaire M, Maugendre D, Moreno M, Le Goff MC, Allannic H, Genetet B. Impaired leucocyte functions in diabetic patients. Diabet Med 1997; 14:29-34.
14. Peter E, Bakri F, Ball DM, Cheney RT, Segal BH. Invasive pulmonary filamentous fungal infection in a patient receiving inhaled corticosteroid therapy. Clin Infect Dis 2002; 35:e54-6.
15. Kennedy CC, Limper AH. Redefining the clinical spectrum of chronic pulmonary histoplasmosis: a retrospective case series of 46 patients. Medicine (Baltimore) 2007; 86:252-8.
16. Cano MV, Ponce-de-Leon GF, Tippen S, Lindsley MD, Warwick M, Hajjeh RA. Blastomycosis in Missouri: epidemiology and risk factors for endemic disease. Epidemiol Infect 2003; 131:907-14.
17. Kauffman CA, Pappas PG, McKinsey DS, et al. Treatment of lymphocutaneous and visceral sporotrichosis with fluconazole. Clin Infect Dis 1996; 22:46-50.
18. Carneiro-Sampaio M, Coutinho A. Immunity to microbes: lessons from primary immunodeficiencies. Infect Immun 2007; 75:1545-55.
19. MacDougall L, Fyfe M, Romney M, Starr M, Galanis E. Risk factors for Cryptococcus gattii infection, British Columbia, Canada. Emerg Infect Dis 2011; 17:193-9.
20. Harris JR, Lockhart SR, Debess E, et al. Cryptococcus gattii in the United States: clinical aspects of infection with an emerging pathogen. Clin Infect Dis 2011; 53:1188-95.
21. Clancy CJ, Wingard JR, Hong Nguyen M. Subcutaneous phaeohyphomycosis in transplant recipients: review of the literature and demonstration of in vitro synergy between antifungal agents. Med Mycol 2000; 38:169-75.
22. Benedict LM, Kusne S, Torre-Cisneros J, Hunt SJ. Primary cutaneous fungal infection after solid-organ transplantation: report of five cases and review. Clin Infect Dis 1992; 15:17-21.
23. Ben-Ami R, Lewis RE, Raad II, Kontoyiannis DP. Phaeohyphomycosis in a tertiary care cancer center. Clin Infect Dis 2009; 48:1033-41.
24. Marriott DJ, Wong KH, Aznar E, Harkness JL, Cooper DA, Muir D. Scytalidium dimidiatum and Lecythophora hoffmannii: unusual causes of fungal infections in a patient with AIDS. J Clin Microbiol 1997; 35:2949-52.
25. Neumeister B, Zollner TM, Krieger D, Sterry W, Marre R. Mycetoma due to Exophiala jeanselmei and Mycobacterium chelonae in a 73- year-old man with idiopathic CD4+ T lymphocytopenia. Mycoses 1995; 38:271-6.
26. O'Riordan E, Denton J, Taylor PM, Kerr J, Short CD. Madura foot in the U.K.: fungal osteomyelitis after renal transplantation. Transplantation 2002; 73:151-3.
27. Van Etta LL, Peterson LR, Gerding DN. Acremonium falciforme (Cephalosporium falciforme) mycetoma in a renal transplant patient. Arch Dermatol 1983; 119:707-8.
28. Meis JF, Schouten RA, Verweij PE, Dolmans W, Wetzels JF. Atypical presentation of Madurella mycetomatis mycetoma in a renal transplant patient. Transpl Infect Dis 2000; 2:96-8.
29. Padmavathy L, Rao IL, Selvam SS, Sahoo CG. Disseminated cutaneous rhinosporidiosis in a HIV sero-positive patient. Indian J Dermatol Venereol Leprol 2001; 67:332-3.
30. Ribes JA, Vanover-Sams CL, Baker DJ. Zygomycetes in human disease. Clin Microbiol Rev 2000; 13:236-301.
31. Walker SD, Clark RV, King CT, Humphries JE, Lytle LS, Butkus DE. Fatal disseminated Conidiobolus coronatus infection in a renal transplant patient. Am J Clin Pathol 1992; 98:559-64.
32. Walsh TJ, Renshaw G, Andrews J, et al. Invasive zygomycosis due to Conidiobolus incongruus. Clin Infect Dis 1994; 19:423-30.
33. Lopez Martinez R, Mendez Tovar LJ. Chromoblastomycosis. Clin Dermatol 2007; 25:188-94.
34. Virgili A, Zampino MR. Relapsing tinea capitis by Microsporum canis in an adult female renal transplant recipient. Nephron 1998; 80:61-2.
35. Garcia-Hermoso D, Janbon G, Dromer F. Epidemiological evidence for dormant Cryptococcus neoformans infection. J Clin Microbiol 1999; 37:3204-9.
36. Ampel NM. Emerging disease issues and fungal pathogens associated with HIV infection. Emerg Infect Dis 1996; 2:109-16.
37. Supparatpinyo K, Khamwan C, Baosoung V, Nelson KE, Sirisanthana T. Disseminated Penicillium marneffei infection in Southeast Asia. Lancet 1994; 344:110-3.
38. Wheat LJ, Connolly-Stringfield PA, Baker RL, et al. Disseminated histoplasmosis in the acquired immune deficiency syndrome: clinical findings, diagnosis and treatment, and review of the literature. Medicine 1990; 69:361-74.
39. Warnock DW, Dupont B, Kauffman CA, Sirisanthana T. Imported mycoses in Europe. Med Mycol 1998; 36(suppl 1):87-94.
40. Steele KT, Thakur R, Nthobatsang R, Steenhoff AP, Bisson GP. Inhospital mortality of HIV-infected cryptococcal meningitis patients with C. gattii and C. neoformans infection in Gaborone, Botswana. Med Mycol 2010; 48:1112-5.
41. Colombo AL, Tobon A, Restrepo A, Queiroz-Telles F, Nucci M. Epidemiology of endemic systemic fungal infections in Latin America. Med Mycol 2011; 49:785-98.
42. McKinsey DS, Spiegel RA, Hutwagner L, et al. Prospective study of histoplasmosis in patients infected with human immunodeficiency virus: incidence, risk factors, and pathophysiology. Clin Infect Dis 1997; 24:1195-203.
43. Dupont B, Crewe Brown HH, Westermann K, et al. Mycoses in AIDS. Med Mycol 2000; 38(suppl 1):259-67.
44. Peigne V, Dromer F, Elie C, Lidove O, Lortholary O. Imported acquired immunodeficiency syndrome-related histoplasmosis in metropolitan France: a comparison of pre-highly active anti-retroviral therapy and highly active anti-retroviral therapy eras. Am J Trop Med Hyg 2011; 85:934-41.
45. Loulergue P, Bastides F, Baudouin V, et al. Literature review and case histories of Histoplasma capsulatum var. duboisii infections in HIVinfected patients. Emerg Infect Dis 2007; 13:1647-52.
46. Bronnimann DA, Adam RD, Galgiani JN, et al. Coccidioidomycosis in the acquired immunodeficiency syndrome. Ann Intern Med 1987; 106:372-9.
47. Woods CW, McRill C, Plikaytis BD, et al. Coccidioidomycosis in human immunodeficiency virus-infected persons in Arizona, 1994- 1997: incidence, risk factors, and prevention. J Infect Dis 2000; 181:1428-34.
48. Deng Z, Ribas JL, Gibson DW, Connor DH. Infections caused by Penicillium marneffei in China and Southeast Asia: review of eighteen published cases and report of four more Chinese cases. Rev Infect Dis 1988; 10:640-52.
49. Sobottka I, Albrecht H, Mack D, et al. Systemic Penicillium marneffei infection in a German AIDS patient. Eur J Clin Microbiol Infect Dis 1996; 15:256-9.
50. Karp CL, Neva FA. Tropical infectious diseases in human immunodeficiency virus-infected patients. Clin Infect Dis 1999; 28:947-63; quiz 64-5.
51. Goldani LZ, Sugar AM. Paracoccidioidomycosis and AIDS: an overview. Clin Infect Dis 1995; 21:1275-81.
52. Pappas PG, Pottage JC, Powderly WG, et al. Blastomycosis in patients with the acquired immunodeficiency syndrome. Ann Intern Med 1992; 116:847-53.
53. al-Tawfiq JA, Wools KK. Disseminated sporotrichosis and Sporothrix schenckii fungemia as the initial presentation of human immunodeficiency virus infection. Clin Infect Dis 1998; 26:1403-6.
54. Rocha MM, Dassin T, Lira R, Lima EL, Severo LC, Londero AT. Sporotrichosis in patient with AIDS: report of a case and review. Rev Iberoam Micol 2001; 18:133-6.
55. Singh N, Huprikar S, Burdette SD, Morris MI, Blair JE, Wheat LJ, and the American Society of Transplantation, Infectious Diseases Community of Practice, Donor-Derived Fungal Infection Working Group. Donor-derived fungal infections in organ transplant recipients: guidelines of the American Society of Transplantation, Infectious Diseases Community of Practice. Am J Transplant 2012; 12:2414-28.
56. Almond CS, Gauvreau K, Canter CE, Rajagopal SK, Piercey GE, Singh TP. A risk-prediction model for in-hospital mortality after heart transplantation in US children. Am J Transplant 2012; 12:1240-8.
57. Freifeld AG, Iwen PC, Lesiak BL, Gilroy RK, Stevens RB, Kalil AC. Histoplasmosis in solid organ transplant recipients at a large Midwestern university transplant center. Transpl Infect Dis 2005; 7:109-15.
58. Shah SS, Karnak D, Shah SN, et al. Broncholith caused by donoracquired histoplasmosis in a lung transplant recipient. J Heart Lung Transplant 2007; 26:407-10.
59. Limaye AP, Connolly PA, Sagar M, et al. Transmission of Histoplasma capsulatum by organ transplantation. N Engl J Med 2000; 343:1163-6.
60. Botterel F, Romand S, Saliba F, et al. A case of disseminated histoplasmosis likely due to infection from a liver allograft. Eur J Clin Microbiol Infect Dis 1999; 18:662-4.
61. Grim SA, Proia L, Miller R, et al. A multicenter study of histoplasmosis and blastomycosis after solid organ transplantation. Transpl Infect Dis 2012; 14:17-23.
62. Brugiere O, Forget E, Biondi G, et al. Coccidioidomycosis in a lung transplant recipient acquired from the donor graft in France. Transplantation 2009; 88:1319-20.
63. Shoham S, Hinestrosa F, Moore J, Jr, O'Donnell S, Ruiz M, Light J. Invasive filamentous fungal infections associated with renal transplant tourism. Transpl Infect Dis 2010; 12:371-4.
64. Vigna-Perez M, Hernandez-Castro B, Paredes-Saharopulos O, et al. Clinical and immunological effects of rituximab in patients with lupus nephritis refractory to conventional therapy: a pilot study. Arthritis Res Ther 2006; 8:R83.
65. Wallis RS, Broder M, Wong J, Lee A, Hoq L. Reactivation of latent granulomatous infections by infliximab. Clin Infect Dis 2005; 41 (suppl 3):S194-8.
66. Pillay VK, Wilson DM, Ing TS, Kark RM. Fungus infection in steroidtreated systemic lupus erythematosus. JAMA 1968; 205:261-5.
67. Mertz LE, Blair JE. Coccidioidomycosis in rheumatology patients: incidence and potential risk factors. Ann N Y Acad Sci 2007; 1111:343-57.
68. Olson TC, Bongartz T, Crowson CS, Roberts GD, Orenstein R, Matteson EL. Histoplasmosis infection in patients with rheumatoid arthritis, 1998-2009. BMC Infect Dis 2011; 11:145.
69. Roy V, Hammerschmidt DE. Disseminated histoplasmosis following prolonged low-dose methotrexate therapy. Am J Hematol 2000; 63:59-60.
70. Nakelchik M, Mangino JE. Reactivation of histoplasmosis after treatment with infliximab. Am J Med 2002; 112:78.
71. Johnson WM, Gall EP. Fatal coccidioidomycosis in collagen vascular diseases. J Rheumatol 1983; 10:79-84.
72. Hage CA, Ribes JA, Wengenack NL, et al. A multicenter evaluation of tests for diagnosis of histoplasmosis. Clin Infect Dis 2011; 53:448-54.
73. Hansen KE, St Clair EW. Disseminated histoplasmosis in systemic lupus erythematosus: case report and review of the literature. Semin Arthritis Rheum 1998; 28:193-9.
74. Lee JH, Slifman NR, Gershon SK, et al. Life-threatening histoplasmosis complicating immunotherapy with tumor necrosis factor alpha antagonists infliximab and etanercept. Arthritis Rheum 2002; 46:2565-70.
75. Bergstrom L, Yocum DE, Ampel NM, et al. Increased risk of coccidioidomycosis in patients treated with tumor necrosis factor alpha antagonists. Arthritis Rheum 2004; 50:1959-66.
76. Baughman RP, Lower EE. Fungal infections as a complication of therapy for sarcoidosis. QJM 2005; 98:451-6.
77. Ross JJ, Katz JD. Cryptococcal meningitis and sarcoidosis. Scand J Infect Dis 2002; 34:937-9.
78. Deresinski SC, Stevens DA. Coccidioidomycosis in compromised hosts. Experience at Stanford University Hospital. Medicine 1975; 54:377-95.
79. Wong SS, Wong KH, Hui WT, et al. Differences in clinical and laboratory diagnostic characteristics of penicilliosis marneffei in human immunodeficiency virus (HIV)- and non-HIV-infected patients. J Clin Microbiol 2001; 39:4535-40.
80. Jones O, Cleveland KO, Gelfand MS. A case of disseminated histoplasmosis following autologous stem cell transplantation for Hodgkin's lymphoma: an initial misdiagnosis with a false-positive serum galactomannan assay. Transpl Infect Dis 2009; 11:281-3.
81. Uyemura K, Castle SC, Makinodan T. The frail elderly: role of dendritic cells in the susceptibility of infection. Mech Ageing Dev 2002; 123:955-62.
82. Vallejo AN. Is Immune aging a cause of disease among the elderly, or is it a passive indicator of general decline of physiologic function? Aging Dis 2011; 2:444-8.
83. Kauffman CA. Fungal infections in older adults. Clin Infect Dis 2001; 33:550-5.
84. Baddley JW, Winthrop KL, Patkar NM, et al. Geographic distribution of endemic fungal infections among older persons, United States. Emerg Infect Dis 2011; 17:1664-9.
85. Schneider E, Hajjeh RA, Spiegel RA, et al. A coccidioidomycosis outbreak following the Northridge, Calif, earthquake. JAMA 1997; 277:904-8.
86. Flaherman VJ, Hector R, Rutherford GW. Estimating severe coccidioidomycosis in California. Emerg Infect Dis 2007; 13:1087-90.
87. Gray GC, Fogle EF, Albright KL. Risk factors for primary pulmonary coccidioidomycosis hospitalizations among United States Navy and Marine Corps personnel, 1981-1994. Am J Trop Med Hyg 1998; 58:309-12.
88. Blair JE, Mayer AP, Currier J, Files JA, Wu Q. Coccidioidomycosis in elderly persons. Clin Infect Dis 2008; 47:1513-8.
89. Sunenshine RH, Anderson S, Erhart L, et al. Public health surveillance for coccidioidomycosis in Arizona. Ann N Y Acad Sci 2007; 1111:96-102.
90. Wheat LJ, Slama TG, Norton JA, et al. Risk factors for disseminated or fatal histoplasmosis. Analysis of a large urban outbreak. Ann Intern Med 1982; 96:159-63.
91. Kralt D, Light B, Cheang M, et al. Clinical characteristics and outcomes in patients with pulmonary blastomycosis. Mycopathologia 2009; 167:115-24.
92. Bercovitch RS, Catanzaro A, Schwartz BS, Pappagianis D, Watts DH, Ampel NM. Coccidioidomycosis during pregnancy: a review and recommendations for management. Clin Infect Dis 2011; 53:363-8.
93. Smale LE, Waechter KG. Dissemination of coccidioidomycosis in pregnancy. Am J Obstet Gynecol 1970; 107:356-61.
94. Whitt SP, Koch GA, Fender B, Ratnasamy N, Everett ED. Histoplasmosis in pregnancy: case series and report of transplacental transmission. Arch Intern Med 2004; 164:454-8.
95. Lemos LB, Soofi M, Amir E. Blastomycosis and pregnancy. Ann Diagn Pathol 2002; 6:211-5.
96. Rosenstein NE, Emery KW, Werner SB, et al. Risk factors for severe pulmonary and disseminated coccidioidomycosis: Kern County, California, 1995-1996. Clin Infect Dis 2001; 32:708-15.
97. Santelli AC, Blair JE, Roust LR. Coccidioidomycosis in patients with diabetes mellitus. Am J Med 2006; 119:964-9.
98. Abbott KC, Hypolite I, Tveit DJ, Hshieh P, Cruess D, Agodoa LY. Hospitalizations for fungal infections after initiation of chronic dialysis in the United States. Nephron 2001; 89:426-32.
99. Rose FB, Camp CJ, Chisdak M. Disseminated histoplasmosis and asplenia. Ann Intern Med 1982; 96(6 Pt 1):790.
100. Naina HV, Thomas CF Jr, Harris S. Histoplasmosis and asplenia. Thorax 2010; 65:372.
101. Blair JE. Coccidioidomycosis in liver transplantation. Liver Transpl 2006; 12:31-9.
102. Chapman SW, Dismukes WE, Proia LA, et al. Clinical practice guidelines for the management of blastomycosis: 2008 update by the Infectious Diseases Society of America. Clin Infect Dis 2008; 46: 1801-12.
103. Galgiani JN. Coccidioidomycosis: a regional disease of national importance. Rethinking approaches for control. Ann Intern Med 1999; 130(4 Pt 1):293-300.
104. Galgiani JN, Ampel NM, Blair JE, et al. Coccidioidomycosis. Clin Infect Dis 2005; 41:1217-23.
105. Wheat LJ, Freifeld AG, Kleiman MB, et al. Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America. Clin Infect Dis 2007; 45:807-25.
106. Yorgin PD, Rewari M, al-Uzri AY, Theodorou AA, Scott KM, Barton LL. Coccidioidomycosis in adolescents with lupus nephritis. Pediatr Nephrol 2001; 16:77-81.
107. Vergidis P, Walker RC, Kaul DR, et al. False-positive Aspergillus galactomannan assay in solid organ transplant recipients with histoplasmosis. Transpl Infect Dis 2012; 14:213-7.
108. Van Der Veer J, Lewis RJ, Emtiazjoo AM, Allen SD, Wheat LJ, Hage CA. Cross-reactivity in the Platelia Aspergillus enzyme immunoassay caused by blastomycosis. Med Mycol 2012; 50:396-8.
109. Hage CA, Bowyer S, Tarvin SE, Helper D, Kleiman MB, Joseph Wheat L. Recognition, diagnosis, and treatment of histoplasmosis complicating tumor necrosis factor blocker therapy. Clin Infect Dis 2010; 50:85-92.
110. Vincent P. The immunocompromised traveller. S Afr J Epidemiol Infect 2008; 23:5.
111. Centers for Disease Control and Prevention. Health information for international travel 2012. The yellow book. Gary W. Brunette, ed. Available at: http://wwwnc.cdc.gov/travel/page/yellowbook-2012-home. htm. Accessed 25 November 2012.
112. Public Health Agency of Canada. About CATMAT. Available at: http ://www.phac-aspc.gc.ca/tmp-pmv/catmat-ccmtmv/index-eng.php. Accessed 25 November 2012.
113. Chariyalertsak S, Supparatpinyo K, Sirisanthana T, Nelson KE. A controlled trial of itraconazole as primary prophylaxis for systemic fungal infections in patients with advanced human immunodeficiency virus infection in Thailand. Clin Infect Dis 2002; 34:277-84.
114. Springer DJ, Chaturvedi V. Projecting global occurrence of Cryptococcus gattii. Emerg Infect Dis 2010; 16:14-20.
115. Cristini A, Garcia-Hermoso D, Celard M, Albrand G, Lortholary O. Cerebral phaeohyphomycosis caused by Rhinocladiella mackenziei in a woman native to Afghanistan. J Clin Microbiol 2010; 48:3451-4.
116. Cano MV, Hajjeh RA. The epidemiology of histoplasmosis: a review. Semin Respir Infect 2001; 16:109-18.
117. Chariyalertsak S, Sirisanthana T, Supparatpinyo K, Nelson KE. Seasonal variation of disseminated Penicillium marneffei infections in northern Thailand: a clue to the reservoir? J Infect Dis 1996; 173:1490-3.